ℹ️
🇬🇧
Search
Search for publications relevant for "nemalobuněčný karcinom plic (NSCLC)"
nemalobuněčný karcinom plic (NSCLC)
Publication
Class
Person
Publication
Programmes
publication
What else after the failure of the first line EFGR-TKI treatment
2015 |
Faculty of Medicine in Pilsen
publication
Research Report University Hospital of the clinical trial 1200.55
Publication without faculty affiliation
publication
Identification of an optimal algorithm for effective diagnostics of non-small cell lung cancer with ALK gene rearrangement - implementation of the method and practical experiences with routine diagnostics
2017 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Pacient s diseminovaným NSCLC s fúzí ROS1 s téměř kompletní remisí na biologické léčbě - kazuistika
2021 |
Publication without faculty affiliation
publication
Efficiency and safety of pemetrexed and cisplatin therapy in the adenocarcinoma and large cell cancer types of advanced non-small cell lung cancer (NSCLC)
2012 |
Publication without faculty affiliation
publication
New options of expensive pneumo-oncological therapy for advanced non-small-cell lung carcinoma (NSCLC) in the first line based on morphological and molecular genetic diagnosis in the Czech Republic
2012 |
Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine
publication
Dlouhodobá léčebná odpověď na crizotinib u pacientky s adenokarcinomem plic
2017 |
First Faculty of Medicine
publication
Clinical experience with durvalumab treatment
2021 |
First Faculty of Medicine
publication
Afatinib as first-line therapy of advanced lung cancer
2014 |
First Faculty of Medicine
publication
Dlouhodobé přežívání pacientky s ALK pozitivním metastatickým adenokarcinomem plic
2019 |
First Faculty of Medicine
publication
The current standard of NSCLC pathological examination in the Czech Republic
2022 |
Faculty of Medicine in Hradec Králové
publication
Indikace durvalumabu v léčbě pacientů s bronchogenním karcinomem
2023 |
First Faculty of Medicine
publication
Přínos sekvenování nové generace v terapii nemalobuněčného plicního karcinomu - zaměřeno na rezistence u EGFR mutovaného nemalobuněčného plicního karcinomu
2023 |
First Faculty of Medicine
publication
Present and new trends in the treatment of non-small cell lung cancer
2016 |
Publication without faculty affiliation
publication
Monitoring of the expensive pneumooncological first-line treatment of the advanced non-small cell lung cancer in the TULUNG register in the Czech Republic
2017 |
Faculty of Medicine in Pilsen, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Nonsmall cell lung cancer with RET gene fusion
2021 |
Publication without faculty affiliation
publication
Lorlatinib in the treatment of non-small cell lung cancer
2020 |
First Faculty of Medicine
publication
Immunotherapy in the first line treatment of non-small cell lung cancer
2020 |
Faculty of Medicine in Pilsen
publication
Immunotherapy in squamous NSCLC - nivolumab clinical data, our experiences with nivolumab treatment
2018 |
Faculty of Medicine in Pilsen